StonvexLoading…
StonvexStonvexStonvexCore line items from CREX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $16.35M | $57.23M | $33.31M | $22.76M |
Operating Income | $-6.21M | $-8.87M | $-9.32M | $-2.05M |
Net Income | $-7.46M | $-8.28M | $-6.31M | $1.55M |
EPS (Diluted) | $-0.74 | $-0.81 | $-0.60 | $0.15 |
Total Assets | $138.25M | $151.04M | $61.27M | $63.65M |
Total Liabilities | $97.11M | $101.85M | $39.38M | $34.21M |
Cash & Equivalents | $1.83M | $1.56M | $314.00K | $569.00K |
Free Cash Flow OCF − CapEx | $-1.91M | $-8.06M | $-1.04M | $664.00K |
Shares Outstanding | 10.57M | 10.52M | 10.52M | 10.52M |